文献速递疝与腹壁外科围术期管理与 ERAS

地塞米松对腹腔镜腹股沟疝修补术后尿潴留的影响

Effects of dexamethasone on postoperative urinary retention after laparoscopic inguinal hernia repair.
PubMed 文献 · Surg Endosc · 2018-11-07

该回顾性队列研究纳入2009至2017年单中心979例男性腹腔镜腹股沟疝修补术患者,比较使用地塞米松组(623例)与未使用组(356例)的术后尿潴留发生率。结果显示地塞米松组尿潴留发生率显著低于未使用组(3.7% vs. 9.8%,p=0.0001),多因素分析显示地塞米松与尿潴留风险降低相关(OR 0.52,95%CI 0.2-0.97,p=0.0386)。亚组分析未发现地塞米松剂量与尿潴留率之间存在显著关联。

要点

  • 地塞米松组术后尿潴留发生率为3.7%,未使用组为9.8%,差异显著。
  • 多因素分析显示地塞米松与尿潴留风险降低独立相关(OR 0.52)。
  • 地塞米松剂量与尿潴留率无显著关联(OR 1.07)。

核心结论

  • 接受地塞米松的患者术后尿潴留发生率更低,且与剂量无关。
  • 地塞米松可用于减少男性腹腔镜腹股沟疝修补术后尿潴留。

研究设计与样本

  • 回顾性队列研究,选取2009至2017年单中心前瞻性数据库中的979例连续患者。
  • 仅纳入男性患者,所有手术由四名普通外科医生完成。
  • 分为地塞米松组(n=623)和未使用地塞米松组(n=356)。
  • 采用卡方检验和独立样本t检验比较围术期因素,并运用单变量和多变量逻辑回归分析。

主要发现

  • 地塞米松组与未使用组术后尿潴留发生率分别为3.7%和9.8%,差异有统计学意义(p=0.0001)。
  • 地塞米松组住院时间更短,且合并良性前列腺增生或留置导尿管的可能性更低(均p<0.05)。
  • 两组年龄和BMI相似。
  • 多因素分析显示地塞米松使用与尿潴留风险降低相关(OR 0.52,95%CI 0.2-0.97,p=0.0386)。
  • 亚组分析显示地塞米松剂量每增加1mg与尿潴留无显著关联(OR 1.07,95%CI 0.82-1.38,p=0.6241)。

临床怎么用

  • 对于接受腹腔镜腹股沟疝修补术的男性患者,可考虑围术期使用地塞米松以降低术后尿潴留风险。
  • 地塞米松的剂量效应不显著,临床决策时无需过度关注剂量差异。

局限性

  • 回顾性研究设计可能存在选择偏倚。
  • 仅纳入男性患者,结果不能推广至女性。
  • 单中心研究,外部有效性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative urinary retention (POUR) is a complication of laparoscopic inguinal hernia repair (LIHR). Previous research has identified predictive factors of POUR, such as age and history of benign prostatic hyperplasia (BPH). There is currently limited work on preventative measures. We hypothesize dexamethasone, a steroid, reduces POUR rates following LIHR due to its mechanism. METHODS: Consecutive patients (n = 979) undergoing LIHR from 2009 to 2017 at a single institution were selected from a prospectively managed database. All procedures were performed by four general surgeons. Only male patients were selected, as the majority of POUR occurs in males. Patients were retroactively chart reviewed and divided into two groups, dexamethasone use (n = 623) and no dexamethasone use (n = 356). Perioperative factors were compared between groups with Chi-square and independent samples t tests. Univariable and multivariable logistic regression analysis was used to assess whether dexamethasone use was associated with POUR. A subgroup analysis was performed on the dexamethasone group to determine any dose-dependent effects. RESULTS: We found a significant difference in POUR between the dexamethasone group and no dexamethasone group (3.7% vs. 9.8%, p = 0.0001). Patients in the dexamethasone group had a shorter length of stay, and were less likely to have BPH or a Foley placed (all p < 0.05). Age and BMI were similar between groups. Multivariable analysis showed that the use of dexamethasone was associated with a reduced risk of POUR (OR 0.52, 95% CI 0.2-0.97, p = 0.0386), while controlling for factors such as age and BPH. A subgroup analysis examined the effect of dexamethasone per unit (mg) increase. There was no significant association between dexamethasone dose and POUR rates (OR 1.07, 95% CI 0.82-1.38, p = 0.6241). CONCLUSIONS: Patients who received dexamethasone showed a lower rate of POUR regardless of dose. These results suggest dexamethasone can be administered to reduce POUR in males undergoing LIHR.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Denham M, Donovan K, Wetoska N, et al. Effects of dexamethasone on postoperative urinary retention after laparoscopic inguinal hernia repair. Surg Endosc. 2018. PMID: 30406386. doi:10.1007/s00464-018-6572-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。